A Phase II, Multicenter, Randomized, Double Blind, Placebo-Controlled, Parallel-arm, Dose Comparason Study of the Efficacy and Safety of the Oral Formulation of OPC-6535 Tablets

  • De Villiers, Willem (PI)
  • VARILEK, GARY (Former PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/8/00 → 8/28/03